GP vs PF as Induction Chemotherapy Combined With CCRT for Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Recruiting
Trial end date:
2026-02-14
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the survival and toxicity of GP (gemcitabine and
cisplatin) vs. PF (cisplatin and fluorouracil) as induction chemotherapy combined with
concurrent chemoradiotherapy (CCRT) for locoregionally advanced nasopharyngeal carcinoma( NPC
) patients.
Phase:
Phase 3
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Affiliated Cancer Hospital & Institute of Guangzhou Medical University First Affiliated Hospital, Sun Yat-Sen University Guangdong General Hospital Guangdong Provincial People's Hospital